Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB Cause Ejection fraction decreased? 39 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Ejection fraction decreased have been filed in association with INFLIXIMAB (Renflexis). This represents 0.0% of all adverse event reports for INFLIXIMAB.

39
Reports of Ejection fraction decreased with INFLIXIMAB
0.0%
of all INFLIXIMAB reports
5
Deaths
13
Hospitalizations

How Dangerous Is Ejection fraction decreased From INFLIXIMAB?

Of the 39 reports, 5 (12.8%) resulted in death, 13 (33.3%) required hospitalization, and 11 (28.2%) were considered life-threatening.

Is Ejection fraction decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 39 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB Cause?

Off label use (34,801) Drug ineffective (33,738) Condition aggravated (16,616) Rheumatoid arthritis (16,251) Pain (15,061) Fatigue (13,473) Arthralgia (13,441) Infusion related reaction (12,946) Product use issue (12,752) Drug intolerance (11,173)

What Other Drugs Cause Ejection fraction decreased?

SACUBITRIL\VALSARTAN (2,551) TRASTUZUMAB (1,579) DOXORUBICIN (834) CYCLOPHOSPHAMIDE (754) PERTUZUMAB (644) DOCETAXEL (520) PACLITAXEL (466) BISOPROLOL (314) RITUXIMAB (296) CARVEDILOL (284)

Which INFLIXIMAB Alternatives Have Lower Ejection fraction decreased Risk?

INFLIXIMAB vs INFLIXIMAB-ABDA INFLIXIMAB vs INFLIXIMAB-AXXQ INFLIXIMAB vs INFLIXIMAB-DYYB INFLIXIMAB vs INFLIXIMAB-QBTX INFLIXIMAB vs INFLIXIMAB, RECOMBINANT

Related Pages

INFLIXIMAB Full Profile All Ejection fraction decreased Reports All Drugs Causing Ejection fraction decreased INFLIXIMAB Demographics